Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Rong Zhang

Showing results (191-200 of 448) with videos related to

Pageof 45
Sort By:
The International Journal of Neuropsychopharmacology|October 2, 2025
A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorderSho Moriguchi, Keisuke Takahata, Harumasa Takano, et al.
Chemical Communications (Cambridge, England)|February 28, 2019
Developing native peptide-based radiotracers for PD-L1 PET imaging and improving imaging contrast by pegylationKuan Hu, Hu Kuan, Masayuki Hanyu, et al.
Nuclear Medicine and Biology|July 9, 2010
Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1Kazuhiko Yanamoto, Fujiko Konno, Chika Odawara, et al.
Molecular Imaging and Biology|April 10, 2010
Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using [(11)C]GF120918 by PET in miceKazunori Kawamura, Tomoteru Yamasaki, Fujiko Konno, et al.
Plos One|October 3, 2013
A small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladderYosuke Nakatani, Michiyuki Suzuki, Masaki Tokunaga, et al.
Bioorganic & Medicinal Chemistry|January 5, 2017
Synthesis and evaluation of 1-(cyclopropylmethyl)-4-(4-[<sup>11</sup>C]methoxyphenyl)-piperidin-1-yl-2-oxo-1,2-dihydropyridine-3-carbonitrile ([<sup>11</sup>C]CMDC) for PET imaging of metabotropic glutamate receptor 2 in the rat brainYufei Ma, Katsushi Kumata, Joji Yui, et al.
Plos One|January 28, 2014
Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protectionYukie Yoshii, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.
Theranostics|October 14, 2021
Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography studyTomoteru Yamasaki, Akiko Hatori, Yiding Zhang, et al.
EJNMMI Radiopharmacy and Chemistry|May 13, 2025
Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracersXiyan Rui, Yuzhou Ding, Nailian Zhang, et al.
Nuclear Medicine Communications|September 23, 2010
PET study on mice bearing human colon adenocarcinoma cells using [11C]GF120918, a dual radioligand for P-glycoprotein and breast cancer resistance proteinTomoteru Yamasaki, Kazunori Kawamura, Akiko Hatori, et al.
Pageof 45

Showing results (191-200 of 448) with videos related to

Sort By:
Pageof 45
The International Journal of Neuropsychopharmacology|October 2, 2025
A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorderSho Moriguchi, Keisuke Takahata, Harumasa Takano, et al.
Chemical Communications (Cambridge, England)|February 28, 2019
Developing native peptide-based radiotracers for PD-L1 PET imaging and improving imaging contrast by pegylationKuan Hu, Hu Kuan, Masayuki Hanyu, et al.
Nuclear Medicine and Biology|July 9, 2010
Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1Kazuhiko Yanamoto, Fujiko Konno, Chika Odawara, et al.
Molecular Imaging and Biology|April 10, 2010
Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using [(11)C]GF120918 by PET in miceKazunori Kawamura, Tomoteru Yamasaki, Fujiko Konno, et al.
Plos One|October 3, 2013
A small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladderYosuke Nakatani, Michiyuki Suzuki, Masaki Tokunaga, et al.
Bioorganic & Medicinal Chemistry|January 5, 2017
Synthesis and evaluation of 1-(cyclopropylmethyl)-4-(4-[<sup>11</sup>C]methoxyphenyl)-piperidin-1-yl-2-oxo-1,2-dihydropyridine-3-carbonitrile ([<sup>11</sup>C]CMDC) for PET imaging of metabotropic glutamate receptor 2 in the rat brainYufei Ma, Katsushi Kumata, Joji Yui, et al.
Plos One|January 28, 2014
Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protectionYukie Yoshii, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.
Theranostics|October 14, 2021
Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography studyTomoteru Yamasaki, Akiko Hatori, Yiding Zhang, et al.
EJNMMI Radiopharmacy and Chemistry|May 13, 2025
Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracersXiyan Rui, Yuzhou Ding, Nailian Zhang, et al.
Nuclear Medicine Communications|September 23, 2010
PET study on mice bearing human colon adenocarcinoma cells using [11C]GF120918, a dual radioligand for P-glycoprotein and breast cancer resistance proteinTomoteru Yamasaki, Kazunori Kawamura, Akiko Hatori, et al.
Pageof 45